Fresenius Medical Care’s revised CEC model looks more attractive

FME & DAV’s main objection has been removed CMS released a revised request for applications for CEC (http://goo.gl/HW5arJ), whereby dialysis care providers would provide care for patients outside the clinic. The previous request allowed CMS to claw back any cost savings that the care providers via a rebasing of the comparison base. The most recent proposal removes this provision which may make the proposal more attractive to dialysis care providers.

FME & DAV still treated differently, but not necessarily worse Large Dialysis Organisations (LDOs), i.e Fresenius Medical and DaVita, are exposed to more benefits, and risks, than Small Dialysis Organisations (SDOs). LDOs are expected to make 4% savings after 4 years before they can benefit from any upside, against some SDOs at 2%. However LDOs could take up to 75% of savings above this rate up to a maximum to 15% of total cost whilst SDOs split savings 50/50 up to a maximum of 5% of total cost. The detail of the model has not been released as yet but we see no provision that would allow SDOs to be treated like LDOs or vice versa if they so choose.

Is Fresenius Medical already getting ready? Fresenius Medical earlier this week announced an agreement with Joslin Diabetes Center to help care for diabetic patients before they have been diagnosed with kidney failure and so need dialysis (or kidney transplant). This is a clear commitment to the strategy announced at the recent Capital Markets Day to expand their care beyond dialysis even without CMS’s CEC plan. Fortune favours the prepared…
[+] source: UBS

About the author

Avatar
ETX Capital
ETX Capital provides institutional, high net worth and retail customers with multi-asset and multi-market derivative dealing capability through spread betting and CFD products.

Leave a Reply

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.